{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:02:00Z","timestamp":1788307320278,"version":"build-2803163510"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.3032","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T15:31:14Z","timestamp":1587137474000},"page":"e203032","source":"Crossref","is-referenced-by-count":18,"title":["Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction"],"prefix":"10.1001","volume":"3","author":[{"given":"Suzanne V.","family":"Arnold","sequence":"first","affiliation":[{"name":"St Luke\u2019s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Liu","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Mues","sequence":"additional","affiliation":[{"name":"Amgen Inc, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[{"name":"St Luke\u2019s Mid America Heart Institute, University of Missouri-Kansas City, Kansas City"},{"name":"The George Institute for Global Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"issue":"20","key":"zld200024r1","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.117.029160","article-title":"Hospital variation in adherence rates to secondary prevention medications and the implications on quality.","volume":"137","author":"Mathews","year":"2018","journal-title":"Circulation"},{"issue":"19","key":"zld200024r2","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jacc.2013.04.102","article-title":"Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.","volume":"62","author":"Arnold","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"zld200024r3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/heartjnl-2014-306754","article-title":"Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.","volume":"101","author":"Shore","year":"2015","journal-title":"Heart"},{"issue":"1","key":"zld200024r4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.","volume":"170","author":"Mathews","year":"2015","journal-title":"Am Heart J"},{"issue":"17","key":"zld200024r5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jacc.2011.06.050","article-title":"Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?","volume":"58","author":"Motivala","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zld200024r6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","article-title":"Post-myocardial infarction (MI) care: medication adherence for secondary prevention after MI in a large real-world population.","volume":"41","author":"Huber","year":"2019","journal-title":"Clin Ther"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764650\/arnold_2020_ld_200024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T15:31:16Z","timestamp":1587137476000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3032","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]}}}